First plaintiff in Zantac litigation drops suit against drug manufacturers
JURIST
AUGUST 17, 2022
The first plaintiff scheduled to go to trial against drug manufacturers for the heartburn medication Zantac Tuesday dropped his suit. ranitidine) caused him to develop esophageal cancer, told the court and drug manufacturers that he intended to file a notice of voluntary dismissal. Joseph Bayer, who claimed Zantac (also known as ??ranitidine)
Let's personalize your content